Company intelligence / Profile preview

BW Pharm

Ownership: Private
Development stage: Preclinical

Overview

BWT Pharma & Biotech, part of the global BWT Group, specializes in providing ultra-pure media supplies—primarily purified water and Water for Injection systems—for pharmaceutical and biotechnology manufacturing. Their solutions are critical infrastructure components used in producing medicines, medical devices, vaccines, infusions, and more. They do not develop drugs themselves but enable safe pharmaceutical production through advanced water treatment technologies.

Industry: Chemicals & Materials

Drug pipeline

1 asset

n-acetylcysteine

Pre-clinical

Indications: Cellular senescence

Beyond the preview

Go deeper on BW Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BW Pharm.

Explore the full profile